nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—asthma—chronic obstructive pulmonary disease	0.498	1	CtDrD
Fluticasone furoate—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0448	0.259	CbGbCtD
Fluticasone furoate—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0423	0.244	CbGbCtD
Fluticasone furoate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0186	0.107	CbGbCtD
Fluticasone furoate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0125	0.0723	CbGbCtD
Fluticasone furoate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.012	0.069	CbGbCtD
Fluticasone furoate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0107	0.0615	CbGbCtD
Fluticasone furoate—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0104	0.0602	CbGbCtD
Fluticasone furoate—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.0104	0.0389	CrCrCtD
Fluticasone furoate—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.0104	0.0389	CrCrCtD
Fluticasone furoate—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.0104	0.0387	CrCrCtD
Fluticasone furoate—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.0101	0.0378	CrCrCtD
Fluticasone furoate—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00986	0.0569	CbGbCtD
Fluticasone furoate—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00983	0.0367	CrCrCtD
Fluticasone furoate—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.0098	0.0366	CrCrCtD
Fluticasone furoate—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00957	0.0357	CrCrCtD
Fluticasone furoate—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00955	0.0357	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00955	0.0357	CrCrCtD
Fluticasone furoate—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00955	0.0357	CrCrCtD
Fluticasone furoate—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00932	0.0348	CrCrCtD
Fluticasone furoate—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00932	0.0348	CrCrCtD
Fluticasone furoate—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00932	0.0348	CrCrCtD
Fluticasone furoate—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00931	0.0348	CrCrCtD
Fluticasone furoate—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00908	0.0339	CrCrCtD
Fluticasone furoate—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00908	0.0339	CrCrCtD
Fluticasone furoate—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00887	0.0331	CrCrCtD
Fluticasone furoate—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00887	0.0331	CrCrCtD
Fluticasone furoate—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00887	0.0331	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00887	0.0331	CrCrCtD
Fluticasone furoate—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00886	0.0331	CrCrCtD
Fluticasone furoate—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00866	0.0324	CrCrCtD
Fluticasone furoate—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00866	0.0324	CrCrCtD
Fluticasone furoate—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00865	0.0323	CrCrCtD
Fluticasone furoate—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00865	0.0323	CrCrCtD
Fluticasone furoate—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00865	0.0323	CrCrCtD
Fluticasone furoate—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00865	0.0323	CrCrCtD
Fluticasone furoate—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00846	0.0316	CrCrCtD
Fluticasone furoate—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00846	0.0316	CrCrCtD
Fluticasone furoate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00626	0.0361	CbGbCtD
Fluticasone furoate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00591	0.0341	CbGbCtD
Fluticasone furoate—Posterior subcapsular cataract—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.0264	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.0213	CcSEcCtD
Fluticasone furoate—Throat irritation—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.0185	CcSEcCtD
Fluticasone furoate—Dry throat—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.0174	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Prednisolone—chronic obstructive pulmonary disease	0.000907	0.0157	CcSEcCtD
Fluticasone furoate—Throat irritation—Formoterol—chronic obstructive pulmonary disease	0.000866	0.0149	CcSEcCtD
Fluticasone furoate—Throat irritation—Arformoterol—chronic obstructive pulmonary disease	0.000866	0.0149	CcSEcCtD
Fluticasone furoate—Throat irritation—Salbutamol—chronic obstructive pulmonary disease	0.000818	0.0141	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Salbutamol—chronic obstructive pulmonary disease	0.000818	0.0141	CcSEcCtD
Fluticasone furoate—Pharyngolaryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.000802	0.0138	CcSEcCtD
Fluticasone furoate—Laryngeal pain—Tiotropium—chronic obstructive pulmonary disease	0.000795	0.0137	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.0135	CcSEcCtD
Fluticasone furoate—Growth retardation—Prednisone—chronic obstructive pulmonary disease	0.000758	0.0131	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.013	CcSEcCtD
Fluticasone furoate—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.000719	0.0124	CcSEcCtD
Fluticasone furoate—Cataract subcapsular—Prednisone—chronic obstructive pulmonary disease	0.000659	0.0114	CcSEcCtD
Fluticasone furoate—Dysphonia—Tiotropium—chronic obstructive pulmonary disease	0.000658	0.0114	CcSEcCtD
Fluticasone furoate—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.000581	0.01	CcSEcCtD
Fluticasone furoate—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.01	CcSEcCtD
Fluticasone furoate—Cataract—Tiotropium—chronic obstructive pulmonary disease	0.000569	0.00982	CcSEcCtD
Fluticasone furoate—Impaired healing—Prednisolone—chronic obstructive pulmonary disease	0.000547	0.00945	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Prednisolone—chronic obstructive pulmonary disease	0.000538	0.00929	CcSEcCtD
Fluticasone furoate—Dysphonia—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.00917	CcSEcCtD
Fluticasone furoate—Dysphonia—Formoterol—chronic obstructive pulmonary disease	0.000531	0.00917	CcSEcCtD
Fluticasone furoate—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.000517	0.00892	CcSEcCtD
Fluticasone furoate—Dysphonia—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00866	CcSEcCtD
Fluticasone furoate—Herpes simplex—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00819	CcSEcCtD
Fluticasone furoate—Herpes simplex—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00819	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00778	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00778	CcSEcCtD
Fluticasone furoate—Herpes simplex—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00773	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.000437	0.00754	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.000437	0.00754	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.000425	0.00734	CcSEcCtD
Fluticasone furoate—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.000417	0.0072	CcSEcCtD
Fluticasone furoate—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.0072	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00712	CcSEcCtD
Fluticasone furoate—Impaired healing—Prednisone—chronic obstructive pulmonary disease	0.000398	0.00686	CcSEcCtD
Fluticasone furoate—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00675	CcSEcCtD
Fluticasone furoate—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000391	0.00674	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00039	0.00673	CcSEcCtD
Fluticasone furoate—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00644	CcSEcCtD
Fluticasone furoate—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.000364	0.00629	CcSEcCtD
Fluticasone furoate—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00621	CcSEcCtD
Fluticasone furoate—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000353	0.00609	CcSEcCtD
Fluticasone furoate—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000344	0.00594	CcSEcCtD
Fluticasone furoate—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000333	0.00574	CcSEcCtD
Fluticasone furoate—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00543	CcSEcCtD
Fluticasone furoate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000305	0.00527	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000301	0.0052	CcSEcCtD
Fluticasone furoate—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00509	CcSEcCtD
Fluticasone furoate—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.000286	0.00493	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.0049	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000284	0.0049	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000278	0.0048	CcSEcCtD
Fluticasone furoate—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00466	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00462	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.00461	CcSEcCtD
Fluticasone furoate—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00455	CcSEcCtD
Fluticasone furoate—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00455	CcSEcCtD
Fluticasone furoate—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.00452	CcSEcCtD
Fluticasone furoate—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000259	0.088	CbGpPWpGaD
Fluticasone furoate—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00446	CcSEcCtD
Fluticasone furoate—Herpes simplex—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00443	CcSEcCtD
Fluticasone furoate—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00439	CcSEcCtD
Fluticasone furoate—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.0043	CcSEcCtD
Fluticasone furoate—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.00424	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00423	CcSEcCtD
Fluticasone furoate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000244	0.00421	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000238	0.0041	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.0041	CcSEcCtD
Fluticasone furoate—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00406	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00402	CcSEcCtD
Fluticasone furoate—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00398	CcSEcCtD
Fluticasone furoate—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00395	CcSEcCtD
Fluticasone furoate—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000229	0.0778	CbGpPWpGaD
Fluticasone furoate—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00394	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000226	0.00391	CcSEcCtD
Fluticasone furoate—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000226	0.0039	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00387	CcSEcCtD
Fluticasone furoate—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000222	0.00383	CcSEcCtD
Fluticasone furoate—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00376	CcSEcCtD
Fluticasone furoate—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00376	CcSEcCtD
Fluticasone furoate—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00376	CcSEcCtD
Fluticasone furoate—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.00373	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00372	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00372	CcSEcCtD
Fluticasone furoate—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00368	CcSEcCtD
Fluticasone furoate—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00365	CcSEcCtD
Fluticasone furoate—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00365	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00365	CcSEcCtD
Fluticasone furoate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00021	0.00363	CcSEcCtD
Fluticasone furoate—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000209	0.00361	CcSEcCtD
Fluticasone furoate—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00357	CcSEcCtD
Fluticasone furoate—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00355	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00354	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00352	CcSEcCtD
Fluticasone furoate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00351	CcSEcCtD
Fluticasone furoate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000203	0.00351	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00347	CcSEcCtD
Fluticasone furoate—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00342	CcSEcCtD
Fluticasone furoate—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00342	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00341	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00341	CcSEcCtD
Fluticasone furoate—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00335	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00334	CcSEcCtD
Fluticasone furoate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000194	0.00334	CcSEcCtD
Fluticasone furoate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000194	0.00334	CcSEcCtD
Fluticasone furoate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000193	0.00332	CcSEcCtD
Fluticasone furoate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.00331	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00327	CcSEcCtD
Fluticasone furoate—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00323	CcSEcCtD
Fluticasone furoate—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000187	0.0636	CbGpPWpGaD
Fluticasone furoate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00322	CcSEcCtD
Fluticasone furoate—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00319	CcSEcCtD
Fluticasone furoate—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00319	CcSEcCtD
Fluticasone furoate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000183	0.00315	CcSEcCtD
Fluticasone furoate—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00314	CcSEcCtD
Fluticasone furoate—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.00313	CcSEcCtD
Fluticasone furoate—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00312	CcSEcCtD
Fluticasone furoate—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00309	CcSEcCtD
Fluticasone furoate—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00309	CcSEcCtD
Fluticasone furoate—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00303	CcSEcCtD
Fluticasone furoate—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00303	CcSEcCtD
Fluticasone furoate—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00303	CcSEcCtD
Fluticasone furoate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00301	CcSEcCtD
Fluticasone furoate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00301	CcSEcCtD
Fluticasone furoate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00301	CcSEcCtD
Fluticasone furoate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00297	CcSEcCtD
Fluticasone furoate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00295	CcSEcCtD
Fluticasone furoate—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00292	CcSEcCtD
Fluticasone furoate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00291	CcSEcCtD
Fluticasone furoate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00291	CcSEcCtD
Fluticasone furoate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00288	CcSEcCtD
Fluticasone furoate—Cough—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00288	CcSEcCtD
Fluticasone furoate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00286	CcSEcCtD
Fluticasone furoate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00285	CcSEcCtD
Fluticasone furoate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00285	CcSEcCtD
Fluticasone furoate—Cough—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00282	CcSEcCtD
Fluticasone furoate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00281	CcSEcCtD
Fluticasone furoate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.0028	CcSEcCtD
Fluticasone furoate—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.317	CrCbGaD
Fluticasone furoate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00275	CcSEcCtD
Fluticasone furoate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00272	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00269	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00269	CcSEcCtD
Fluticasone furoate—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.306	CrCbGaD
Fluticasone furoate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00267	CcSEcCtD
Fluticasone furoate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00267	CcSEcCtD
Fluticasone furoate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00265	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00264	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00264	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00264	CcSEcCtD
Fluticasone furoate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00262	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00261	CcSEcCtD
Fluticasone furoate—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00259	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00259	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00254	CcSEcCtD
Fluticasone furoate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00252	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00249	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00246	CcSEcCtD
Fluticasone furoate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.00242	CcSEcCtD
Fluticasone furoate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.0024	CcSEcCtD
Fluticasone furoate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000139	0.0024	CcSEcCtD
Fluticasone furoate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.00234	CcSEcCtD
Fluticasone furoate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00227	CcSEcCtD
Fluticasone furoate—Dexamethasone—NOS2—chronic obstructive pulmonary disease	0.000131	0.259	CrCbGaD
Fluticasone furoate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.00223	CcSEcCtD
Fluticasone furoate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.00223	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00222	CcSEcCtD
Fluticasone furoate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.00222	CcSEcCtD
Fluticasone furoate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00221	CcSEcCtD
Fluticasone furoate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00214	CcSEcCtD
Fluticasone furoate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00214	CcSEcCtD
Fluticasone furoate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00213	CcSEcCtD
Fluticasone furoate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00213	CcSEcCtD
Fluticasone furoate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.0021	CcSEcCtD
Fluticasone furoate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.0021	CcSEcCtD
Fluticasone furoate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.0021	CcSEcCtD
Fluticasone furoate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00209	CcSEcCtD
Fluticasone furoate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.00209	CcSEcCtD
Fluticasone furoate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00208	CcSEcCtD
Fluticasone furoate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00202	CcSEcCtD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000117	0.0396	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00201	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00198	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00198	CcSEcCtD
Fluticasone furoate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.00198	CcSEcCtD
Fluticasone furoate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00198	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00194	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00187	CcSEcCtD
Fluticasone furoate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00184	CcSEcCtD
Fluticasone furoate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00184	CcSEcCtD
Fluticasone furoate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000105	0.0018	CcSEcCtD
Fluticasone furoate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00178	CcSEcCtD
Fluticasone furoate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00178	CcSEcCtD
Fluticasone furoate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00174	CcSEcCtD
Fluticasone furoate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00174	CcSEcCtD
Fluticasone furoate—Rash—Arformoterol—chronic obstructive pulmonary disease	9.83e-05	0.0017	CcSEcCtD
Fluticasone furoate—Rash—Formoterol—chronic obstructive pulmonary disease	9.83e-05	0.0017	CcSEcCtD
Fluticasone furoate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.82e-05	0.0017	CcSEcCtD
Fluticasone furoate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.82e-05	0.0017	CcSEcCtD
Fluticasone furoate—Headache—Arformoterol—chronic obstructive pulmonary disease	9.77e-05	0.00169	CcSEcCtD
Fluticasone furoate—Headache—Formoterol—chronic obstructive pulmonary disease	9.77e-05	0.00169	CcSEcCtD
Fluticasone furoate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.74e-05	0.00168	CcSEcCtD
Fluticasone furoate—Rash—Montelukast—chronic obstructive pulmonary disease	9.63e-05	0.00166	CcSEcCtD
Fluticasone furoate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.62e-05	0.00166	CcSEcCtD
Fluticasone furoate—Headache—Montelukast—chronic obstructive pulmonary disease	9.57e-05	0.00165	CcSEcCtD
Fluticasone furoate—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	9.5e-05	0.0323	CbGpPWpGaD
Fluticasone furoate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.00163	CcSEcCtD
Fluticasone furoate—Rash—Salbutamol—chronic obstructive pulmonary disease	9.28e-05	0.0016	CcSEcCtD
Fluticasone furoate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.28e-05	0.0016	CcSEcCtD
Fluticasone furoate—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.26e-05	0.0016	CcSEcCtD
Fluticasone furoate—Nausea—Formoterol—chronic obstructive pulmonary disease	9.26e-05	0.0016	CcSEcCtD
Fluticasone furoate—Headache—Salbutamol—chronic obstructive pulmonary disease	9.23e-05	0.00159	CcSEcCtD
Fluticasone furoate—Nausea—Montelukast—chronic obstructive pulmonary disease	9.07e-05	0.00157	CcSEcCtD
Fluticasone furoate—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.75e-05	0.00151	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.00147	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.45e-05	0.00146	CcSEcCtD
Fluticasone furoate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.00139	CcSEcCtD
Fluticasone furoate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.00135	CcSEcCtD
Fluticasone furoate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	7.28e-05	0.0247	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	7.24e-05	0.0246	CbGpPWpGaD
Fluticasone furoate—Agitation—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.00119	CcSEcCtD
Fluticasone furoate—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.00119	CcSEcCtD
Fluticasone furoate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.71e-05	0.00116	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.22e-05	0.00107	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.00106	CcSEcCtD
Fluticasone furoate—Infection—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.00105	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	6.02e-05	0.119	CrCbGaD
Fluticasone furoate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.00104	CcSEcCtD
Fluticasone furoate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	5.65e-05	0.0192	CbGpPWpGaD
Fluticasone furoate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.59e-05	0.000964	CcSEcCtD
Fluticasone furoate—Rash—Prednisolone—chronic obstructive pulmonary disease	5.33e-05	0.000919	CcSEcCtD
Fluticasone furoate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.32e-05	0.000918	CcSEcCtD
Fluticasone furoate—Headache—Prednisolone—chronic obstructive pulmonary disease	5.29e-05	0.000913	CcSEcCtD
Fluticasone furoate—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.02e-05	0.000866	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	4.91e-05	0.0167	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	4.91e-05	0.0167	CbGpPWpGaD
Fluticasone furoate—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000841	CcSEcCtD
Fluticasone furoate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000837	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.52e-05	0.00078	CcSEcCtD
Fluticasone furoate—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	4.46e-05	0.0152	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	4.36e-05	0.0148	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	4.28e-05	0.0145	CbGpPWpGaD
Fluticasone furoate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000725	CcSEcCtD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	4.1e-05	0.0139	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	4.1e-05	0.0139	CbGpPWpGaD
Fluticasone furoate—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.0007	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	4.06e-05	0.0138	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	3.95e-05	0.0134	CbGpPWpGaD
Fluticasone furoate—Rash—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000668	CcSEcCtD
Fluticasone furoate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000667	CcSEcCtD
Fluticasone furoate—Headache—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000664	CcSEcCtD
Fluticasone furoate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	3.75e-05	0.0127	CbGpPWpGaD
Fluticasone furoate—Nausea—Prednisone—chronic obstructive pulmonary disease	3.65e-05	0.000629	CcSEcCtD
Fluticasone furoate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	3.56e-05	0.0121	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	3.53e-05	0.012	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	3.49e-05	0.0118	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	3.42e-05	0.0116	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	3.35e-05	0.0114	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	3.26e-05	0.0111	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.24e-05	0.011	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	3.1e-05	0.0105	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	2.98e-05	0.0101	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	2.97e-05	0.0101	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.94e-05	0.00998	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2.91e-05	0.00989	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.87e-05	0.00974	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	2.82e-05	0.00956	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	2.73e-05	0.00928	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	2.72e-05	0.00924	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	2.7e-05	0.00919	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	2.68e-05	0.00912	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	2.65e-05	0.009	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.61e-05	0.00888	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	2.5e-05	0.0085	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	2.48e-05	0.00842	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	2.11e-05	0.00716	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.00716	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	2e-05	0.00681	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	1.99e-05	0.00675	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.91e-05	0.00648	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.84e-05	0.00624	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	1.82e-05	0.00619	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.75e-05	0.00594	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.74e-05	0.00592	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.72e-05	0.00586	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.7e-05	0.00579	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	1.7e-05	0.00578	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.00571	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.00571	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.63e-05	0.00552	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.63e-05	0.00552	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	1.62e-05	0.00549	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.0052	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	1.51e-05	0.00512	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.45e-05	0.00494	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.42e-05	0.00483	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.00469	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.37e-05	0.00466	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.27e-05	0.00431	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.00421	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.00415	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.17e-05	0.00398	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.1e-05	0.00373	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	1.07e-05	0.00364	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	1.03e-05	0.0035	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1e-05	0.00341	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.00341	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.64e-06	0.00327	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	9.44e-06	0.00321	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.3e-06	0.00316	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.92e-06	0.00303	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.83e-06	0.003	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.73e-06	0.00296	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.72e-06	0.00296	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	8.66e-06	0.00294	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.16e-06	0.00277	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.09e-06	0.00275	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.55e-06	0.00257	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.34e-06	0.00249	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.24e-06	0.00246	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.99e-06	0.00238	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.96e-06	0.00236	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.93e-06	0.00236	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.53e-06	0.00222	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.47e-06	0.0022	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.12e-06	0.00208	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.04e-06	0.00205	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.64e-06	0.00192	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.62e-06	0.00191	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.55e-06	0.00188	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.33e-06	0.00181	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.29e-06	0.0018	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.26e-06	0.00179	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.01e-06	0.0017	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.93e-06	0.00168	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.61e-06	0.00157	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.49e-06	0.00152	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.29e-06	0.00146	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.17e-06	0.00142	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.73e-06	0.00127	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.58e-06	0.00122	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.42e-06	0.00116	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.35e-06	0.00114	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.19e-06	0.00109	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.84e-06	0.000965	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.82e-06	0.000957	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.76e-06	0.000939	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.57e-06	0.000873	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.45e-06	0.000833	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.42e-06	0.000823	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.41e-06	0.00082	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.21e-06	0.000751	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.15e-06	0.00073	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.04e-06	0.000692	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.7e-06	0.000577	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.68e-06	0.000569	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.56e-06	0.00053	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.51e-06	0.000513	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-06	0.000507	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.48e-06	0.000503	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-06	0.000463	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-06	0.000426	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-06	0.000356	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-06	0.000351	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-06	0.000342	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.62e-07	0.000327	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.62e-07	0.000327	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.12e-07	0.00031	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.2e-07	0.000211	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.93e-07	0.000201	CbGpPWpGaD
